THOMAS P MAC MAHON
CIK 1168580 · last filed 2022-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.65M
Companies
4
Total Filings
94
Lifetime Open-Market Net
-$144.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ortho Clinical Diagnostics Holdings plc (OCDX) Delisted | Director | 141,853 | $17.63 | $2.50M | $0 | 2 | 2021-12-17 |
| Express Scripts Holding Co. (ESRX) Delisted | Director | 0 | — | — | -$6.61M | 24 | 2018-12-21 |
| PharMerica CORP (PMC) Delisted | Director | 58,606 | — | — | -$153.9K | 13 | 2016-06-21 |
| LH | Director | 37,594 | $283.36 | $10.65M | -$137.24M | 54 | 2012-09-10 |
Recent Filings · Page 2 of 10
94 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-06 | Express Scripts Holding Co. (ESRX) Delisted | Grant (A) | +1,374 | $0 | EDGAR |
| 2016-05-03 | Express Scripts Holding Co. (ESRX) Delisted | Mixed | +7,646 | -$564 | EDGAR |
| 2015-06-23 | PharMerica CORP (PMC) Delisted | Grant (A) | +3,730 | $0 | EDGAR |
| 2015-05-08 | Express Scripts Holding Co. (ESRX) Delisted | Grant (A) | +1,189 | $0 | EDGAR |
| 2014-11-25 | Express Scripts Holding Co. (ESRX) Delisted | Mixed | — | -$572.3K | EDGAR |
| 2014-03-11 | PharMerica CORP (PMC) Delisted | Sell (S) | −10,000 | -$249.3K | EDGAR |
| 2013-11-19 | PharMerica CORP (PMC) Delisted | Mixed | +3,294 | -$11 | EDGAR |
| 2013-11-06 | Express Scripts Holding Co. (ESRX) Delisted | Mixed | — | -$647.9K | EDGAR |
| 2013-07-03 | PharMerica CORP (PMC) Delisted | Grant (A) | +5,556 | $0 | EDGAR |
| 2013-06-19 | PharMerica CORP (PMC) Delisted | Grant (A) | +5,685 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.